Transcanalicular Diode Laser Assisted Dacryocystorhinostomy in Primary Acquired Nasolacrimal Duct Obstruction: 2-Year Follow Up

dc.authorid0000-0001-6442-250X
dc.authorid0000-0002-9778-2322
dc.authorid0000-0001-8197-2458
dc.contributor.authorKaynak, Pelin
dc.contributor.authorOzturker, Can
dc.contributor.authorYazgan, Serpil
dc.contributor.authorKarabulut, Gamze Ozturk
dc.contributor.authorAkar, Serpil
dc.contributor.authorDemirok, Ahmet
dc.contributor.authorYilmaz, Omer F.
dc.date.accessioned2025-05-10T19:38:47Z
dc.date.issued2014
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractPurpose: To evaluate the success rate of 980 nm transcanalicular diode laser-assisted dacryocystorhinostomy (TDL-DCR) in patients with primary acquired nasolacrimal duct obstruction (PANDO) and to consider the time and the reasons of failure. Methods: Hundred and thirty eyes of 125 patients who underwent of TDL-DCR for the treatment of PANDO are included in this retrospective, noncomparative, nonrandomized, interventional study. The mean follow-up time was 24.29 months (range 8-34 months). Functional success was described as disappearance of epiphora and presence of a patent ostium on lacrimal irrigation. Anatomical success was described as a patent ostium to irrigation but continuing epiphora. Patients with persistent epiphora and a closed ostium were classified as a surgical failure. Results: At third month follow up, 85.4% of cases had complete resolution of their symptoms. The functional success rate decreased to 67.7% at 6 months, to 63.3% at first year, and to 60.3% at second year, while the patency of the lacrimal drainage system was restored in 93.1%, 74.6%, 69.5%, and 68.2% of the cases, respectively. The average total amount of delivered laser energy was 1322.7 J. No correlation could be found between the age of the patient, delivered laser energy, and the surgical success (p = 0.38, p = 0.62). Conclusions: Transcanalicular diode laser-assisted DCR is a fast and relatively easy alternative surgical method, which avoids a facial skin scar, to treat PANDO. The functional success rate is higher in the first months but decreases to low 60 %'s at the end of first year and remains the same at the second-year follow up.
dc.identifier.doi10.1097/01.iop.0000437533.66479.f0
dc.identifier.endpage33
dc.identifier.issn0740-9303
dc.identifier.issn1537-2677
dc.identifier.issue1
dc.identifier.pmid24195985
dc.identifier.scopusqualityQ2
dc.identifier.startpage28
dc.identifier.urihttps://doi.org/10.1097/01.iop.0000437533.66479.f0
dc.identifier.urihttps://hdl.handle.net/20.500.14730/9473
dc.identifier.volume30
dc.identifier.wosWOS:000335559600019
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofOphthalmic Plastic and Reconstructive Surgery
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectExternal Dacryocystorhinostomy
dc.subjectLacrimal Surgery
dc.subjectEndonasal Dacryocystorhinostomy
dc.subjectMitomycin-C
dc.subjectDcr Surgery
dc.subjectEndoscope
dc.subjectSuccess
dc.titleTranscanalicular Diode Laser Assisted Dacryocystorhinostomy in Primary Acquired Nasolacrimal Duct Obstruction: 2-Year Follow Up
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
9473.pdf
Boyut:
363.43 KB
Biçim:
Adobe Portable Document Format